Obsessive-Compulsive Disorder Therapy
Study data from Indiana University, Department of Psychiatry update understanding of obsessive-compulsive disorder therapy
Published in Surgery Litigation and Law Weekly, June 27th, 2008
Current study results from the report, 'Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder,' have been published. According to recent research from the United States, "Obsessive-compulsive disorder (OCD) is a disabling psychiatric condition affecting 1-2% of the community. Although modern drug, behavioral and psychosurgical therapies have improved the prognosis of OCD considerably, approximately 30% of patients remain treatment-refractory."
"Currently, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are the drug treatments of choice for OCD. Accordingly, this review evaluates the evidence for a role of the serotonin (5-HT) neurochemical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- ALM Media, Inc.
ALM Events Announces Fifth Annual Cosmeceuticals Conference - American Institute of Physics
Highlights of upcoming acoustics meeting -- June 30 to July 4 in Paris, France - Dentistry
Research from C. Wells and co-authors reveals new findings on dentistry - Education Management Llc
Education Management LLC Announces the Opening of Brown Mackie College - Boise - SurgiCount Medical, Inc.
North Shore Medical Center's Two Hospitals Adopt SurgiCount Computerized Sponge Counting System - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm study findings have been reported by researchers at Medical University of Vienna - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
